Virginia Cancer Specialists-Fairfax

Fairfax, Virginia 22031

1 studies enrolling now · 6 studies all time

What they study most

Breast Adenocarcinoma, Breast Cancer, Estrogen Receptor Negative, HER2-low Hormone Receptor Positive Breast Cancer, HER2/Neu Negative, Melanoma (Skin Cancer), Progesterone Receptor Negative, Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (HNSCC), Relapsed or Refractory Multiple Myeloma, Stage IB Breast Cancer, Stage IIA Breast Cancer, Stage IIB Breast Cancer

Studies at this site

• Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors — Recruiting now
• Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer — Completed
• Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer — Running, not enrolling
• INCB001158 Combined With Subcutaneous (SC) Daratumumab, Compared to Daratumumab SC, in Relapsed or Refractory Multiple Myeloma — Stopped early
• Pepinemab in Combination With Pembrolizumab in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck — Completed
• A Phase 2 Study of Sitravatinib in Combination With PD-(L)1 Checkpoint Inhibitor Regimens in Patients With Advanced or Metastatic Urothelial Carcinoma — Stopped early